Aug 27, 2008
Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer
Aug 27, 2008 - Cell Genesys, Inc. today announced that it has terminated VITAL-2, the second of two Phase 3 clinical trials of GVAX immunotherapy for prostate cancer, which compares GVAX immunotherapy in ...
Read full story from Med Ad News
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Merck to fund Vioxx settlement in August | 1 hr | DJ -SMD | 1319 |
| MPI Research cutting jobs in Mattawan | 3 hr | Harold | 5 |
| Claims administrator: Interim payments in $4.85... | 3 hr | heraldo | 983 |
| Buffalo - The Next Cleveland? | 4 hr | Wow | 14 |
| Cymbalta leads the way for Lilly (from Feb '07) | 4 hr | edd | 232 |
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 5 hr | IronLady | 647 |
| Teva Announces Launch of Generic Zoloft (from Nov '06) | 7 hr | KGH Monroe NC | 1113 |
Taurus
Most Popular